Sign In
Buy ELV
$388.50
-2.77 (-0.708%)
At Close: Jun 18, 2026
Elevance Health (ELV) Q4 Earnings and Revenues Beat Estimates
08:11am, Thursday, 23'rd Jan 2025
Elevance Health (ELV) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares to earnings of $5.62 per share a year ago.
Elevance Health Q4 2024 Earnings: Managed Care Continues To Impress
07:42am, Thursday, 23'rd Jan 2025
Despite a 29% drop in Elevance Health's stock, I maintain a strong buy rating due to a DCF price target of $549.60, indicating 43% upside. ELV's shift towards managed care, with strong industry tailwi
Elevance Stock Gains After Strong Quarter. A Dividend Hike Is Another Positive.
07:35am, Thursday, 23'rd Jan 2025
The health insurer's fourth-quarter adjusted earnings top analysts' estimates.
Elevance Health earnings boost health-insurance stocks after upbeat outlook
07:13am, Thursday, 23'rd Jan 2025
UnitedHealth, Humana and Centene all rally premarket
Elevance beats quarterly profit estimates on lower-than-expected medical costs
06:07am, Thursday, 23'rd Jan 2025
Elevance beat Wall Street estimates for quarterly profit on Thursday, as the health insurer spent less than expected on the medical costs of its members.
Elevance Health Reports Fourth Quarter and Full Year 2024 Results; Sets Full Year 2025 Outlook
06:00am, Thursday, 23'rd Jan 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2024 results. “As part of our commitment to elevating whole health and advancing health beyond
Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools
11:17am, Tuesday, 21'st Jan 2025
CANONSBURG, Pa.--(BUSINESS WIRE)--MFA reviewed Elevance Health's acquisition of Indiana University Health Plans using Medicare Benefits Analyzer and County Health Coverage.
Elevance Health Q4 Countdown: Smart Move to Buy or Stick With Hold?
10:31am, Monday, 20'th Jan 2025
ELV's fourth-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Unveiling Elevance Health (ELV) Q4 Outlook: Wall Street Estimates for Key Metrics
10:20am, Friday, 17'th Jan 2025
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Elevance Health (ELV), delve into some of its key metrics to gain a deeper insight into the company's potential performance for
Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
04:05pm, Thursday, 09'th Jan 2025
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time (“EST”). Managem
My Top 15 High Growth Dividend Stocks For January 2025
10:49pm, Thursday, 02'nd Jan 2025
The SPDR S&P 500 ETF Trust ended 2024 on a sour note, losing 2.41% in December and finishing the year up 24.89%. The Top 15 dividend growth stocks for January 2025 offer an average dividend yield of 1
Elevance Health Is An Undervalued Healthcare Juggernaut
03:01am, Thursday, 26'th Dec 2024
Elevance Health is a strong buy despite a 30% stock decline, due to its solid fundamentals and market position in the health insurance industry. The company benefits from secular trends like an aging
Elevance Health Stock Plunges 29.6% in Q4: Buy, Hold or Sell?
04:01pm, Friday, 20'th Dec 2024
ELV is reallocating resources to more profitable areas and making prudent acquisitions.
Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025
07:00am, Thursday, 12'th Dec 2024
Investing in blue-chip stocks at 52-week lows can potentially yield significant returns if fundamentals are strong. Avoid value traps by focusing on companies with solid fundamentals, like Elevance He
SAN DIEGO, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating Elevance Health Inc. (NASDAQ: ELV) to determine whether certain Elevance officers and directors v
